Profitelligence Profitelligence · Filing Ledger Open CAH research →

Form 8-K · Current Report · Filed 2026-04-30

Cardinal Health Reports Q3 FY26 Results and Raises Outlook

Cardinal Health, Inc. reported a 11% increase in third-quarter fiscal year 2026 revenues to $60.9 billion. GAAP operating earnings decreased 30% to $509 million, while non-GAAP operating earnings increased 18% to $956 million. The company raised its fiscal year 2026 non-GAAP EPS guidance to a range of $10.70 to $10.80. Additionally, Cardinal Health completed an additional $250 million share repurchase, bringing the total year-to-date repurchase to $1.0 billion.

Filer
Cardinal Health Inc. CAH · NYSE
Filed
Accession
0000721371-26-000017
CIK
0000721371
Signal
High impactHealthcare

Items reported

Item events

Reported Item

Earnings Beat Raised Guidance Share Repurchase Program Announced

Market reaction

Close before filing

$202.82

Next session

-3.7%

Since filing

+13.4%

Latest close

$230.03

What happened, not what will happen — closing prices around the filing date.

Precedent

Previous filings from CAH reporting the same item, with the next session's move:

About Cardinal Health Inc.

Cardinal Health Inc. is a major global healthcare services and products company, distinguished for providing end-to-end medical solutions. Specializing in healthcare distribution and supply chain management, Cardinal Health serves a comprehensive array of clients including hospitals, pharmacies, and healthcare providers. Notably, the company distributes pharmaceuticals, medical products, and laboratory supplies, ensuring efficient delivery to improve healthcare outcomes. Based in Dublin, Ohio, Cardinal Health plays a pivotal role in enhancing healthcare operational efficiency, offering extensive services like inventory management, logistics optimization, and integrated healthcare solutions that empower providers to focus on patient care. As one of the largest pharmaceutical distributors in the United States, it holds substantial influence in the healthcare sector, pivotal in ensuring the availability of drugs and medical supplies across various platforms, contributing significantly to the healthcare infrastructure worldwide.

Exchange NYSE Industry Medical Distribution Company website ↗

Never miss another CAH filing

Profitelligence watches EDGAR around the clock and alerts you within seconds.

Set up free alerts